DANYEIL HARVEY: Open Payments
NPI 1386142024 · FAYETTEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 62 payments from 17 companies in 2025. Trend: 2023 $1,335 · 2024 $732 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $227 |
| ABBVIE INC. | 10 | $176 |
| Novo Nordisk Inc | 10 | $169 |
| Lilly USA, LLC | 9 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Amgen Inc. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: Veozah, MOUNJARO, CAPLYTA, VRAYLAR, REXULTI, Ozempic, Auvelity, Wegovy.
Industry payments across TN — which companies pay providers there.
